Caption Management’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.71M Buy
+276,700
New +$4.12M 0.02% 781

Other funds holding CTNM

Caption Management's CTNM Position: Q3 2026 in Review

Caption Management opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 22,000 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Caption Management held 22,000 shares of Contineum Therapeutics worth $295K as of Q3 2026.
  • Contineum Therapeutics was a new Caption Management position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q3 2026, its #1517 holding.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.